Open your account
Empower yourself with cutting-edge tools, expert insights, and unrivaled features.Articles

Kotak Mahindra Bank Q2FY27 Result Update: Growth & Margin Outlook
Kotak Mahindra Bank reported strong standalone performance in Q2FY27, highlighted by broad-based credit expansion of 24.8% YoY and deposit growth of 23.2% YoY supported by FCNR(B) inflows and digital retail channels. Standalone net profit grew 33.2% YoY to Rs 43,000 million, while asset quality continued to strengthen with Gross NPA declining to 1.04% and annualised slippages easing to 0.9%. While net interest margins contracted 22 bps QoQ to 4.31% due to liquidity intake, margin recovery is expected as funds are deployed into higher-yielding customer assets alongside rate transmission, supported by operational leverage and executive leadership clarity.
Other Articles














.png&w=3840&q=75)






CIE Automotive India Q3CY26 Result Update
CIE Automotive India delivered a robust performance in Q3CY26, powered by an 18% YoY revenue surge in its domestic market. Despite facing global macroeconomic headwinds and margin pressures, the company’s strategic focus on order-backed capacity expansion and operational restructuring in Europe has bolstered its long-term growth foundation.

DCB Bank Q2FY27 Result Update: Growth & Margins
DCB Bank Ltd. registered strong business execution in Q2FY27, highlighted by advances growth of 21.1% YoY to 641,270 million and net profit rising 28.5% YoY to 2,360 million. While Net Interest Margin experienced temporary contraction to 3.25% due to short-term excess liquidity carry, asset quality strengthened to multi-quarter lows with Net NPA dropping to 0.73% and PCR reaching 81.4%. With disciplined cost management and steady loan book guidance, the bank continues to progress toward a sustainable return on assets (RoA) delivery.

Colgate-Palmolive Q2FY27 Results: Double-Digit Growth Meets Margin Pressure
Colgate-Palmolive (India) demonstrated strong volume and revenue resilience in Q2FY27, posting a 12.2% YoY rise in net sales to Rs 1,692 Cr, backed by high-single-digit volume expansion in toothpaste and robust traction in Colgate MaxFresh. While gross margin expanded 44 bps to 69.6%, EBITDA margin contracted 289 bps to 28.0% as the company stepped up advertising spends by nearly 40% (Rs 315 Cr) to accelerate premiumisation and reinforce market leadership. Despite elevated operating overheads, net profit advanced 4.3% YoY to Rs 342 Cr, reflecting solid fundamentals and long-term category-building commitment.

Listing Day Explained: What Investors Should Expect
An educational guide to understanding IPO listing day in India. Learn about the special pre-open session timeline (9:00 AM–10:00 AM), price discovery mechanics, listing percentage calculations, and a neutral 5-step investor checklist. Discover how to differentiate short-term listing momentum from long-term business performance and track upcoming IPOs on Axis Direct.

EAAA India Alternatives Limited IPO: Financials and Key Offer Details
The EAAA India Alternatives Limited IPO offers investors a chance to partake in one of India's leading alternative asset management platforms. With a massive Assets Under Management (AUM) of over ₹6,55,000 million and robust profit margins, EAAA is capitalizing on the booming demand for private credit and real assets. Dive into the complete IPO details, financial health, and strategic growth pillars.

Bombay Coated & Special Steels IPO: Complete Analysis, Financials & Growth Strategy
Bombay Coated & Special Steels Limited, a leading multi-location steel processing centre and authorised service partner for JSW Steel Coated Products, has filed for an initial public offering (IPO) aggregating up to ₹1,910.00 million. Catering heavily to the Home & Commercial Appliances sector and General Engineering industries, the company recorded robust revenue of ₹10,557.07 million in FY25 alongside a Profit After Tax of ₹286.72 million. Proceeds from the fresh issue will primarily be deployed toward debt repayment (₹1,250.00 million) and capital equipment acquisition (₹180.00 million) to optimize financial leverage and boost operational efficiency.

M. K. Sons Fine Jewels IPO Analysis: Business, Financials & Growth Strategy
M. K. Sons Fine Jewels Limited has filed its draft prospectus for an initial public offering (IPO) comprising up to 17,000,000 Equity Shares, consisting of a Fresh Issue of up to 13,600,000 Equity Shares and an Offer for Sale of up to 3,400,000 Equity Shares. The company, operating under the brand "MK Jewels", is a retail-focused enterprise specializing in gold, diamond, and Cubic Zirconia jewellery across showrooms in Maharashtra and Gujarat. For the nine-month period ended December 31, 2025, the company recorded a revenue of ₹3,608.21 million and a Profit After Tax (PAT) of ₹291.65 million. Net proceeds from the fresh issue will primarily fund showroom expansion and loan repayments.

Retail vs HNI IPO: Differences, Limits & Allotment
Discover the comprehensive breakdown of Retail vs High Net-Worth Individual (HNI / Non-Institutional Investor) IPO applications in India. Learn about essential eligibility thresholds, including the ₹2 Lakh boundary for retail bidders alongside the Small HNI (sNII: ₹2 Lakh to ₹10 Lakh) and Big HNI (bNII: above ₹10 Lakh) subcategories. Understand how allotment mechanisms operate during heavy oversubscription—from computerized lotteries to minimum NII lot allocations—along with worked mathematical examples, payment guidelines via ASBA and UPI, common application mistakes to avoid, and educational guidance for evaluating IPO applications on Axis Direct.

What Is ASBA? Meaning, IPO Process, Benefits & FAQs
Application Supported by Blocked Amount (ASBA) is SEBI’s mandatory payment framework designed to protect investor capital during public equity offerings, including IPOs, FPOs, and Rights Issues. This comprehensive guide details the operational mechanics of ASBA, explaining how application funds remain securely inside an investor's bank account (such as Axis Bank) while earning daily savings interest until allotment is finalized. It breaks down the step-by-step application workflow across trading platforms like Axis Direct and NetBanking channels, compares ASBA with UPI mandates, provides a detailed numerical analysis of partial allotments and unblocking timelines, and addresses common application errors alongside frequently asked compliance questions.

Difference Between IPO and FPO: A Detailed Guide
An Initial Public Offering (IPO) is launched by an unlisted private firm issuing stock to the public for the first time, whereas a Follow-on Public Offering (FPO) is offered by an already listed company seeking additional public capital. Both structures can be executed as a Fresh Issue (issuing new equity shares to raise corporate funds for expansion or debt reduction) or an Offer for Sale (OFS) (allowing existing promoters or venture funds to sell holdings without expanding total share count). Key investor considerations include evaluating listing status, valuation metrics, DRHP disclosures, fund utilization pathways, and Earnings Per Share (EPS) dilution effects before submitting an ASBA bid.

What Is RHP? DRHP vs RHP: Key Differences Explained
Exploring an upcoming Initial Public Offering (IPO)? Understanding legal offer documents is essential for evaluating any company's true financial health and growth prospects. A Red Herring Prospectus (RHP) serves as the core disclosure document filed with SEBI and the Registrar of Companies (RoC) before an IPO opens for public bidding. Unlike a Draft Red Herring Prospectus (DRHP)—which is an initial draft filed for regulatory observation and public comments—the RHP provides updated financial figures, risk factors, promoter disclosures, and the issue price band or floor price. This practical investor guide breaks down the full IPO offer lifecycle (DRHP vs RHP vs Final Prospectus), details what information to analyze across major sections, provides a practical 4-step checklist for analyzing IPOs, illustrates a worked example, and addresses key frequently asked questions to help you make informed, independent investment decisions.

BLS Polymers Limited IPO - Analysis, Growth Strategy & Financial Highlights
BLS Polymers Limited is a leading manufacturer of custom-formulated polymer compounds catering to critical industries like power, telecommunications, railways, and oil & gas pipeline coatings. The ₹255 million initial public offering comprises up to 17 million fresh equity shares of face value ₹10 each. Revenue from operations reached ₹3,284.36 million in FY25, accompanied by a 180.99% YoY surge in PAT to ₹211.36 million. The net proceeds will primarily fund the expansion of its Goa manufacturing facility and meet working capital requirements.

SFC Environmental Technologies IPO Analysis: Business, Financials & Growth Strategy
SFC Environmental Technologies Limited offers design, engineering, and technology solutions in wastewater treatment, wastewater recycling & reuse, and solid waste treatment. Holding over 80% market share in sequencing batch reactor (SBR) technology in India, the company reported revenue from operations of ₹6,978.58 million and a profit after tax of ₹1,520.08 million in Fiscal 2025. The IPO features a Fresh Issue of ₹1,500.00 million primarily aimed at funding working capital requirements and de-leveraging debt.

Reliance Jio IPO 2026: Date, Price Band, Quota & Key Details
Reliance Jio IPO is the planned listing of Jio Platforms Ltd, the digital and telecom arm of Reliance Industries Ltd and the parent company of Reliance Jio Infocomm Ltd, India’s largest telecom operator with 524.4 million customers as of 31 March 2026. The offer is a 100% fresh issue of up to 27 crore equity shares of face value ₹10 each, with no offer for sale. As per the RHP filed on 14 Oct '26, bidding is open from 21 Oct '26 to 23 Oct '26. The price band is ₹1,065 to ₹1,119 per share and the minimum bid is 12 shares, implying an issue size of about ₹30,213 crore (₹302,130 million) at the upper end. In FY26, revenue from operations rose to ₹1,468,850 million from ₹1,282,180 million in FY25, while profit after tax stood at ₹300,490 million.

Paras Healthcare Limited IPO: Comprehensive Financial Analysis & Growth Strategy
Paras Healthcare Limited, a leading regional healthcare provider operating under the "Paras Health" brand, is expanding its footprint across North and East India. The company operates 8 multi-specialty hospitals with 2,211 beds and has demonstrated a strong financial turnaround in Fiscal 2026, achieving revenues of ₹16,059.52 million and turning profitable with a Net Profit of ₹438.34 million. The Fresh Issue proceeds will be utilized towards debt de-leveraging and investment in expanding operations.
.png&w=3840&q=75)
Biggest IPOs Expected in India in 2026: Companies to Watch
Discover the top mega-IPOs set to hit the Indian stock market in 2026. Explore key company profiles, estimated issue sizes, timelines, valuation checks, and essential evaluation steps for smart investing with Axis Direct.

8-4-3 Rule of SIP: Meaning, Benefits & How It Works
Uncover the power of the 8-4-3 rule of SIP to accelerate your wealth creation journey. Learn how compounding doubles your corpus faster over a 15-year horizon with strategic mutual fund investments through Axis Direct.

What Is AMC in Demat Account? Full Meaning & Charges
A comprehensive guide explaining Demat Account Maintenance Charges (AMC), calculation methods, SEBI BSDA rules, and why choosing Axis Direct provides superior value for investors.

Index Funds vs Mutual Funds: 5 Key Differences
Confused between Index Funds and Mutual Funds? Learn the 5 key differences, expense ratios, management styles, risks, and returns to make smart investment choices on Axis Direct.

Jio IPO Shareholder Quota Guide: DRHP Rules & Dual-Bidding Strategy
Jio Platforms Limited has filed its Draft Red Herring Prospectus (DRHP) with SEBI, establishing a dedicated RIL Shareholder Reservation Portion. This guide highlights the key regulatory features for existing Reliance Industries Limited shareholders: Eligibility Criteria: Requires holding RIL equity shares in settled demat status on the cut-off record date with no minimum shareholding threshold. Strategic Advantage: Allows eligible investors to submit dual applications under the same PAN—one under the RIL Shareholder Quota (up to ₹2,00,000) and a second under either the Retail Individual Investor (RII) or Non-Institutional Investor (NII) category—without application rejection. Filing Status: Outlines confirmed DRHP disclosures (issue structure, promoter details, debt prepayment objects) while noting that price bands, bid lot sizes, record dates, and issue timelines will be confirmed in the final Red Herring Prospectus (RHP).

Sahajanand Medical Technologies Ltd. IPO: Financials and Key Offer Details
Sahajanand Medical Technologies Limited (SMT), a global medical device manufacturer specializing in vascular intervention (VI) and structural heart (SH) devices, is launching its Initial Public Offering (IPO). The offer comprises a 100% Offer for Sale (OFS) of up to 27,644,231 Equity Shares of face value ₹1 each by promoter and investor selling shareholders. Bidding is open from 15 Oct '26 to 19 Oct '26 with a price range of ₹327 - ₹344 per share. In Fiscal 2025, SMT achieved ₹10,248.79 million in revenue from operations—a steady increase from ₹9,016.04 million in FY24, and registered a net profit after tax of ₹251.52 million. Dive into our comprehensive guide to explore SMT's market presence, product portfolio, and long-term growth prospects.


